Previous Article | Next Article 
Journal of Clinical Microbiology, April 1999, p. 912-915, Vol. 37, No. 4
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
PCR-Based Restriction Pattern Typing of the vacA Gene
Provides Evidence for a Homogeneous Group among Helicobacter
pylori Strains Associated with Peptic Ulcer Disease
Manuela
Donati,1
Elisa
Storni,1
Lucia
D'Apote,1
Sandra
Moreno,1
Antonio
Tucci,2
Loris
Poli,2 and
Roberto
Cevenini1,*
Sezione di Microbiologia
DMCSS1 and Dipartimento di Medicina
Interna e Gastroenterologia,2 Policlinico S. Orsola, University of Bologna, Bologna, Italy
Received 23 July 1998/Returned for modification 22 October
1998/Accepted 21 December 1998
 |
ABSTRACT |
The results of PCR-based molecular typing of Helicobacter
pylori strains by restriction fragment length polymorphism
analysis of a 1,161-bp nucleotide sequence of the midregion of the
vacA gene are reported. A total of 48 H. pylori strains isolated from gastric biopsy specimens obtained
from 18 patients with peptic ulcer dyspepsia, 15 patients with nonulcer
dyspepsia, and 15 asymptomatic H. pylori-infected
subjects were studied. Highly heterogeneous restriction patterns were
obtained by digestion of PCR products with SauII,
BglII, and HhaI, whereas HaeIII
digestion resulted in a strictly homogeneous profile for H. pylori strains isolated from 14 of 18 (77.7%) patients with
peptic ulcer dyspepsia, but a strictly homogeneous profile was found
for strains from only 8 of 15 (53.3%) patients with nonulcer dyspepsia
(P = 0.163) and 5 of 15 (33.3%) asymptomatic
H. pylori-infected subjects (P = 0.014). A potentially important aspect of the results obtained is the
clinical relevance, since a single restriction pattern seems to be able
to identify the majority of H. pylori strains associated with peptic ulcer disease.
 |
INTRODUCTION |
Helicobacter pylori
is linked to gastritis, peptic ulcer, and gastric cancer (4,
6, 14). Peptic ulcer disease, as distinct from chronic
asymptomatic infection, is strongly associated with the expression of
bacterial virulence markers (5, 30), including
cytotoxin-associated gene A (CagA) (12, 28) and the
vacuolating cytotoxin (VacA) that induces the formation of intracellular vacuoles in eukaryotic cells in vitro (9, 20).
Most people infected with H. pylori are asymptomatic,
with only a few patients developing peptic ulcer or gastric cancer. A
possible explanation is that patients with serious gastroduodenal lesions are infected with virulent H. pylori strains,
whereas those patients who are asymptomatic and who present with simple chronic gastritis and no ulcer are infected with organisms with low
pathogenic potentials.
Although H. pylori isolates show high levels of
genotypic diversity (16), almost all phenotypic characters
of the microorganism are conserved with the exception of the production
of the vacuolating cytotoxin encoded by vacA (10)
and the presence of the 128-kDa cytotoxin-associated protein encoded by
cagA (7, 10). These two factors are therefore
potentially important virulence determinants that affect the clinical
outcome of H. pylori infection. In particular, the
vacA gene is present in almost all strains tested (11,
22), and about 50% of clinical isolates produce inactive or less
active toxins due to the presence of alleles characterized by
differences in the signal peptide and/or middle region of the gene of
H. pylori isolates obtained from U.S. subjects
(8). By PCR typing and DNA sequencing, Atherton et al.
(2) demonstrated that s1 vacA genotypes are
associated with a higher level of in vitro cytotoxin activity than the
levels of activity with which other genotypes are associated and that
type s1 strains are more frequently observed among patients with past
or present peptic ulceration than patients without peptic ulcer
(2, 3). Recently, the existence of different
allelic variants has also been described in H. pylori strains obtained from European (23, 24, 29) and Japanese (18) subjects.
We report here on a simple PCR-based method of typing H. pylori that uses restriction fragment length polymorphism (RFLP) analysis of a 1,161-bp fragment of the midregion of vacA.
Using this analysis, we found a simple fingerprinting pattern that
identifies most H. pylori strains isolated from
patients with peptic ulcer disease.
 |
MATERIALS AND METHODS |
Patients and clinical specimens.
Forty-eight subjects (23 men and 25 females; mean age, 46 years; age range, 22 to 75 years) were
admitted to the study. Thirty-three patients had undergone
gastroduodenoscopy for dyspepsia, and 15 asymptomatic subjects were the
partners of H. pylori-infected patients. Gastric
specimens were cultured for H. pylori, as described previously (27). Briefly, biopsy samples were homogenized
and cultured on Columbia agar base (Oxoid, Milan, Italy) supplemented with 7% horse blood and Dent's selective supplement (Oxoid). The cultures were incubated in a microaerophilic atmosphere at 37°C in
GasPak jars and CampyPak II envelopes (BBL Microbiology System, Cockeysville, Md.), and the isolates were identified as H. pylori by their morphology upon Gram staining and by positive
urease, oxidase, and catalase tests. Histological sections of
formalin-fixed biopsy specimens were stained with hematoxylin-eosin to
evaluate the morphology and whether Helicobacter-like
organisms were present. A serum sample was obtained by routine
venipuncture for serological studies.
Assay for cytotoxicity.
Supernatants from broth cultures of
H. pylori isolates were concentrated by using
Centriprep-100 ultrafiltration units (Amicon, Beverly, Mass.) and were
incubated with HeLa cells at twofold dilutions ranging from 1:5 to
1:160 as described previously (13). Cell vacuolization was
assessed by light microscopy after 48 h of incubation. Wells in
which 50% or more of the cells were vacuolated were defined as showing
a cytotoxic effect.
Neutralization of H. pylori cytotoxin
activity.
Human sera were heated at 56°C and diluted with
Eagle's minimal essential medium. Sera diluted twofold (from 1:10 to
1:160) were incubated for 1 h at 37°C with an equal volume of
the concentrated type strain H. pylori CCUG 17874 (Culture Collection of the University of Göteborg,
Göteborg, Sweden) culture supernatant. Adherent HeLa cells were
incubated for 18 h at 37°C in 96-well plates with 50-µl
mixtures of serum and H. pylori plus 50 µl of minimal
essential medium. The neutralization titer was defined as the highest
dilution of a serum sample that completely neutralized vacuolization,
as assessed by light microscopy.
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis and
Western blot (immunoblot) analysis for antibodies against VacA and CagA
antigens.
Sodium dodecyl sulfate-polyacrylamide gel
electrophoresis was performed by the method of Laemmli (19)
with a 7.0% acrylamide gel, as described previously (13).
Supernatants from the type strain H. pylori CCUG 17874 broth culture was concentrated by using Centriprep-100 ultrafiltration
units (Amicon) and were used as antigen, as described previously
(13).
The Western blot procedure of Towbin et al. (26) was
performed as described previously (13). Briefly, after
electrophoretic transfer, the blots were incubated for 12 h at
room temperature with human sera diluted 1:1,000 in phosphate-buffered
saline containing 0.05% (vol/vol) Tween 20. Antigen-antibody complexes
were detected with anti-human peroxidase-labeled immunoglobulin G
(DAKO, Copenhagen, Denmark) diluted 1:500 in phosphate-buffered saline
and with 4-chloro-1-naphthol (Bio-Rad, Hercules, Calif.) as the enzyme
substrate. The VacA and CagA antigens were recognized as clear bands of
87 to 94 and 128 kDa, respectively (13).
PCR.
The oligonucleotides used as PCR primers in this study
have been used previously by Xiang et al. (30). The primers
for the vacA gene are derived from the sequence of the
vacA gene. Briefly, the amplification product of
H. pylori vacA primers 5'-GCTTCTCTTACCACCAATGC and 5'-TGTCAGGGTTGTTCACCATG was 1,161 nucleotides in
length and was derived from the middle region of vacA, from
nucleotides 1468 to 2629 (25). H. pylori
cagA primers 5'-AGTAAGGAGAAACAATGA and 5'-AATAAGCCTTAGAGTCTTTTTGGAAATC amplify a 1,350-bp DNA
fragment (30). The PCR mixtures (50 µl) contained 50 mM
KCl, 10 mM Tris, 200 µM (each) deoxynucleoside triphosphate, 30 pmol
of each primer, 2.5 U of Amplitaq (Perkin-Elmer, Norwalk, Conn.), and
10 ng of DNA obtained from each bacterial strain by phenol-chloroform
extraction and ethanol precipitation. Amplifications were performed on
a PCR 9600 thermocycler (Perkin-Elmer) as follows: 94°C for 1 min, 58°C for 1 min, and 72°C for 1 min. Five microliters of the PCR product was electrophoresed on a 2% agarose gel (Bethesda Research Laboratories, Inc., Gaithersburg, Md.) with 1× Tris-borate-EDTA buffer
containing 1 µg of ethidium bromide per ml. The gels were examined by
transillumination and were photographed. A vacA- and cagA-positive H. pylori strain (strain CCUG
17874) and a cagA-negative and vacA-positive
H. pylori strain (strain HPG21) were used as controls
in the PCR experiments.
RFLP analysis.
A 10-µl sample of the PCR product was
digested with 10 U of the restriction enzymes HaeIII,
SauIII, BglII, and HhaI (Boehringer Mannheim) for 4 h at 37°C in the buffer, as recommended by the supplier. The digest was analyzed by electrophoresis in a 2% agarose gel with 1× Tris-borate-EDTA buffer containing 1 µg of ethidium bromide per ml. DNA molecular size marker VI (Boehringer) was used.
Statistical analysis.
Prevalence rates were compared by the
2 test and Fisher's exact test. Probability levels
(P) of <0.1 were considered statistically significant.
 |
RESULTS |
The endoscopic diagnoses for 33 symptomatic patients with
dyspepsia were peptic ulcer dyspepsia (n = 18) and
nonulcer dyspepsia (n = 15). The gastric histology of
the latter 15 patients was active (n = 5) or chronic
active (n = 10) gastritis. The 15 asymptomatic partners
of H. pylori-infected patients were either
histologically negative (n = 7) or the partners
presented with simple chronic histological gastritis (n = 8). All 48 patients studied were positive for H. pylori by culture. Supernatants from 23 of 48 H. pylori isolates produced vacuolization in HeLa cells, whereas
supernatants from the remaining 25 did not. The supernatant dilution
that produced vacuolization ranged from 1:5 to
1:160.
The specific sequences of the vacA and cagA genes
of the H. pylori isolates were looked for by PCR: all
48 strains were vacA positive, whereas 42 strains
possessed the cagA gene (data not shown). The
relationship between the genetic, phenotypic, and serological
properties of the H. pylori strains isolated from the
48 subjects is reported in Table 1.
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Genetic, phenotypic, and serological properties of
H. pylori isolates from 33 patients with gastritis and
endoscopically defined gastroduodenal pathology and 15 asymptomatic H. pylori-infected subjects
|
|
From the restriction enzyme digestion of the 1,161-bp products of
amplification of the vacA gene from the 48 H. pylori strains studied, we found highly heterogeneous restriction
patterns with SauIII, BglII, and HhaI
(data not reported), whereas HaeIII digestion of the
1,161-bp vacA fragment resulted in a strictly homogeneous profile (Fig. 1) for strains from 77.8%
of the patients (14 of 18) with peptic ulcer dyspepsia, whereas a
strictly homogeneous profile was found for strains from 53.3% of the
patients (8 of 15) with nonulcer dyspepsia and chronic active gastritis
(P = 0.163) and 33.3% of the asymptomatic subjects
infected with H. pylori (5 of 15), who had either a
negative histology result or simple chronic gastritis (P = 0.014) (Table 1). All 27 H. pylori strains with
the homogeneous profile were cagA positive, and 17 (63.0%)
produced cytotoxin in vitro. Of 21 strains with the heterogeneous profile, 15 (71.4%) were cagA positive and 6 (28.6%)
produced cytotoxin in vitro.

View larger version (85K):
[in this window]
[in a new window]
|
FIG. 1.
RFLP analysis of H. pylori vacA gene. A
1,161-bp region was amplified by PCR and digested with
HaeIII, and the fragments were separated in a 2% agarose
gel. (a) Homogeneous pattern characterized by three bands. Lanes A and
R, molecular size marker VI; lanes B to O, isolates from 14 patients
with ulcer dyspepsia, respectively; lanes P and Q, isolates from
patients with nonulcer dyspepsia. (b) Heterogeneous profiles
characterized by several different patterns. Lanes A and R, molecular
size marker VI; lanes B to I, isolates from asymptomatic H. pylori-infected patients; lanes J to O, isolates from patients
with nonulcer dyspepsia; lane P, running buffer alone; lane Q, isolate
from a patient with ulcer dyspepsia.
|
|
 |
DISCUSSION |
Although molecular biological typing methods with genomic
DNA or gene probes usually require laborious sample preparation and
processing steps, the use of PCR-based RFLP analysis affords a simple
and rapid typing technique. The molecular typing approach for
H. pylori that uses the PCR-based RFLP analysis has
been used previously. The genes encoding urease and its accessory
proteins have been preferential targets for PCR (1, 17, 21)
since these genes are conserved in H. pylori. The
adhesin gene hpaA (15) has also been used as the
target for comparison of the effects of genetic changes of
H. pylori isolates.
In our study, the vacA gene was the target for the
PCR, and we decided to use a fragment of the midregion of
the gene large enough to permit the detection of diversity but
small enough to allow regular amplification. Previous studies by Cover
et al. (11) and Atherton et al. (2) have shown
that several cytotoxin-producing strains and
cytotoxin-nonproducing strains of H. pylori have
substantially different sequences within the middle region of the
vacA gene. Our results by RFLP analysis of the PCR
products with several restriction enzymes confirmed the high degree of
diversity of the genomic structure of the vacA gene among
H. pylori strains isolated from gastric biopsy
specimens. However, the digestion of PCR products with the
HaeIII enzyme allowed us to identify a genetic correlation
for 27 of 48 H. pylori strains examined, thus resulting
in a homogeneous group of strains with identical vacA gene
restriction patterns characterized by the presence of three distinct
bands. In addition, these strains were strongly associated with the
presence of the cagA gene and cytotoxin activity and
occurred more frequently in patients with peptic ulcer dyspepsia. In
fact, the genetically related strains were isolated from 77.8% of
patients with peptic ulcer dyspepsia but significantly (P = 0.014) less frequently (33.3%) from asymptomatic H. pylori-infected subjects. Although the homogeneous
H. pylori strains were more likely to be isolated
from patients with peptic ulcer dyspepsia (77.8%) than from patients
with nonulcer dyspepsia and chronic active gastritis (53.3%), the
differences were not significant (P = 0.163). The
detection of strains with this characteristic restriction pattern not
only in patients with ulcer dyspepsia but also in patients with a less
serious disease such as nonulcer dyspepsia and chronic active gastritis
or in H. pylori-infected but as yet asymptomatic
subjects showed that the specificity (57.7%) of the pattern for
ulcer disease was lower than its sensitivity (77.8%). This
observation, however, does not seem at variance with the presumed
ulcerogenic potential of these strains. It is well known that chronic
infection often occurs without symptoms and that with time some
individuals develop severe features of upper gastrointestinal diseases.
Untreated chronic infection with these H. pylori
strains may progress from simple chronic gastritis in asymptomatic
subjects to chronic active gastritis in patients with nonulcer
dyspepsia and, finally, to peptic ulcer disease in ulcer patients.
In conclusion, the results of this study by PCR-based restriction
pattern analysis suggest that the specific RFLP profiles reported here
may be indicators of the pathogenic potential of H. pylori strains. A potentially important aspect of this simple method may be its clinical relevance, since a single restriction pattern for the vacA gene seems to be able to identify
H. pylori strains strongly associated with peptic ulcer disease.
 |
ACKNOWLEDGMENT |
This study was partially supported by University of Bologna grant
Finanziamento Speciale alle Strutture.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Sezione di
Microbiologia DMCSS, Policlinco S. Orsola, Via Massarenti 9, 40138 Bologna, Italy. Phone: 39-51-341652. Fax: 39-51-341632. E-mail:
Cevenini{at}almadns.unibo.it.
 |
REFERENCES |
| 1.
|
Akopyanz, N.,
N. O. Bukanov,
T. U. Westblom, and D. E. Berg.
1992.
PCR-based RFLP analysis of DNA sequence diversity in gastric pathogen Helicobacter pylori.
Nucleic Acids Res.
20:6221-6225[Abstract/Free Full Text].
|
| 2.
|
Atherton, J. C.,
P. Cao,
R. M. Peek,
M. K. R. Tummuru,
M. J. Blaser, and T. L. Cover.
1995.
Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori.
J. Biol. Chem.
270:17771-17777[Abstract/Free Full Text].
|
| 3.
|
Atherton, J. C. P.,
R. M. Peek,
K. T. Tham,
T. L. Cover, and M. J. Blaser.
1997.
Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori.
Gastroenterology
112:92-99[Medline].
|
| 4.
|
Blaser, M.
1993.
Helicobacter pylori: microbiology of a "slow" bacterial infection.
Trends Microbiol.
11:255-260.
|
| 5.
|
Blaser, M.
1996.
Role of vacA and the cagA locus of Helicobacter pylori in human disease.
Alimen. Pharmacol. Ther.
10(Suppl. 1):73-78[Medline].
|
| 6.
|
Blaser, M. J., and J. Personnet.
1994.
Parasitism by the "slow" bacterium Helicobacter pylori leads to altered gastric homeostatis and neoplasia.
J. Clin. Invest.
94:4-8.
|
| 7.
|
Covacci, A.,
S. Censini,
M. Bugnoli,
R. Petracca,
D. Burroni,
G. Macchia,
A. Massone,
E. Papini,
Z. Xiang,
N. Figura, and R. Rappuoli.
1993.
Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer.
Proc. Natl. Acad: Sci. USA
90:5791-5795[Abstract/Free Full Text].
|
| 8.
|
Cover, T.
1996.
The vacuolating cytotoxin of Helicobacter pylori.
Mol. Microbiol.
20:241-246[Medline].
|
| 9.
|
Cover, T. L., and M. J. Blaser.
1992.
Purification and characterization of the vacuolating toxin from Helicobacter pylori.
J. Biol. Chem.
267:10570-10575[Abstract/Free Full Text].
|
| 10.
|
Cover, T. L.,
C. P. Dooley, and M. J. Blaser.
1990.
Characterization of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity.
Infect. Immun.
58:603-610[Abstract/Free Full Text].
|
| 11.
|
Cover, T. L.,
M. K. M. Tummuru,
P. Cao,
S. A. Thompson, and M. J. Blaser.
1994.
Divergence of genetic sequences for the vacuolating cytotoxin among Helicobacter pylori strains.
J. Biol. Chem.
269:10566-10573[Abstract/Free Full Text].
|
| 12.
|
Crabtree, J. E.,
N. Figura,
J. D. Taylor,
M. Bugnoli,
D. Armellini, and D. S. Tompkins.
1992.
Expression of 120 kilodalton protein and cytotoxicity in Helicobacter pylori.
J. Clin. Pathol.
45:733-734[Abstract/Free Full Text].
|
| 13.
|
Donati, M.,
S. Moreno,
E. Storni,
A. Tucci,
L. Poli,
A. Mazzoni,
O. Varoli,
V. Sambri,
A. Farencena, and R. Cevenini.
1997.
Detection of serum antibodies to CagA and VacA and of serum neutralizing activity for vacuolating cytotoxin in patients with Helicobacter pylori-induced gastritis.
Clin. Diagn. Lab. Immunol.
4:478-482[Abstract].
|
| 14.
|
Eurogast Study Group.
1993.
An international association between Helicobacter pylori infection and gastric cancer.
Lancet
341:1360-1362.
|
| 15.
|
Evans, D. G.,
D. J. Evans,
H. C. Lampert, and D. Y. Graham.
1995.
Restriction fragment length polymorphism in the adhesin gene hpaA of Helicobacter pylori.
Am. J. Gastroenterol.
90:1282-1288[Medline].
|
| 16.
|
Foxall, P. A.,
L. T. Hu, and H. L. T. Mobley.
1992.
Use of polymerase chain reaction-amplified Helicobacter pylori urease structural genes for differentiation of isolates.
J. Clin. Microbiol.
30:739-741[Abstract/Free Full Text].
|
| 17.
|
Fujimoto, S.,
B. Marshall, and M. J. Blaser.
1994.
PCR-based restriction fragment length polymorphism typing of Helicobacter pylori.
J. Clin. Microbiol.
32:331-334[Abstract/Free Full Text].
|
| 18.
|
Ito, Y.,
T. Azuma,
S. Ito,
H. Miyaji,
M. Hirai,
Y. Yamazaki,
F. Sato,
T. Kato,
Y. Kohli, and M. Kuriyama.
1997.
Analysis and typing of the vacA gene from cagA-positive strains of Helicobacter pylori isolated in Japan.
J. Clin. Microbiol.
35:1710-1714[Abstract].
|
| 19.
|
Laemmli, U. K.
1970.
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
Nature (London)
227:680-685[Medline].
|
| 20.
|
Leunk, R. D.,
P. T. Johnson,
B. C. David,
W. G. Kraft, and D. R. Morgan.
1988.
Cytotoxic activity in broth culture filtrates of Campylobacter pylori.
J. Med. Microbiol.
26:93-99[Abstract].
|
| 21.
|
Moore, R. A.,
A. Kureishi,
S. Wong, and L. E. Bryan.
1993.
Categorization of clinical isolates of Helicobacter pylori on the basis of restriction digest analysis of polymerase chain reaction-amplified ureC genes.
J. Clin. Microbiol.
31:1334-1335[Abstract/Free Full Text].
|
| 22.
|
Phadnis, S. H.,
D. Ilver,
L. Janzon,
S. Normark, and T. U. Westblom.
1994.
Pathological significance and molecular characterization of the vacuolating toxin gene of Helicobacter pylori.
Infect. Immun.
62:1557-1565[Abstract/Free Full Text].
|
| 23.
|
Rudi, J.,
C. Kolb,
M. Maiwald,
D. Kuck,
A. Sieg,
P. R. Galle, and W. Stremmel.
1998.
Diversity of Helicobacter pylori vacA and cagA genes and relationship to VacA and CagA protein expression, cytotoxin production, and associated diseases.
J. Clin. Microbiol.
36:944-948[Abstract/Free Full Text].
|
| 24.
|
Strobel, S.,
S. Bereswill,
P. Balig,
P. Allgaier,
H. G. Sonntag, and M. Kist.
1998.
Identification and analysis of a new vacA genotype variant of Helicobacter pylori in different patient groups in Germany.
J. Clin. Microbiol.
36:1285-1289[Abstract/Free Full Text].
|
| 25.
|
Telford, J. L.,
P. Ghiara,
M. Dell'Orco,
M. Comanducci,
D. Burroni,
M. Bugnoli,
M. F. Tecce,
S. Censini,
A. Covacci,
Z. Xiang,
E. Papini,
C. Montecucco,
L. Parente, and R. Rappuoli.
1994.
Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease.
J. Exp. Med.
179:1653-1658[Abstract/Free Full Text].
|
| 26.
|
Towbin, H.,
T. Staehelin, and J. Gordon.
1979.
Electrophoretic transfer of protein from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.
Proc. Natl. Acad. Sci. USA
76:4350-4354[Abstract/Free Full Text].
|
| 27.
|
Tucci, A.,
L. Poli,
M. Donati,
C. Mazzoni,
R. Cevenini,
V. Sambri,
O. Varoli,
P. Bocus,
A. Ferrari,
G. F. Paparo, and G. Caletti.
1996.
Value of serology (ELISA) for the diagnosis of Helicobacter pylori infection: evaluation in patients attending endoscopy and in those with fundic atrophic gastritis.
Ital. J. Gastroenterol.
28:371-376[Medline].
|
| 28.
|
Tummuru, M. K. R.,
T. L. Cover, and M. J. Blaser.
1993.
Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: evidence of linkage to cytotoxin production.
Infect. Immun.
61:1799-1809[Abstract/Free Full Text].
|
| 29.
|
van Doorn, L. J.,
C. Figueiredo,
R. Rossau,
G. Jannes,
M. van Asbroeck,
J. C. Sousa,
F. Carneiro, and W. G. V. Quint.
1998.
Typing of Helicobacter pylori vacA gene and detection of cagA gene by PCR and reverse hybridization.
J. Clin. Microbiol.
36:1271-1276[Abstract/Free Full Text].
|
| 30.
|
Xiang, Z.,
S. Censini,
P. F. Bayeli,
J. L. Telford,
N. Figura,
R. Rappuoli, and A. Covacci.
1995.
Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin.
Infect. Immun.
63:94-98[Abstract].
|
Journal of Clinical Microbiology, April 1999, p. 912-915, Vol. 37, No. 4
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Lim, C.-Y., Lee, K.-H., Cho, M.-J., Chang, M.-W., Kim, S.-Y., Myong, N.-H., Lee, W.-K., Rhee, K.-H., Kook, Y.-H.
(2003). Detection of Helicobacter pylori in Gastric Mucosa of Patients with Gastroduodenal Diseases by PCR-Restriction Analysis Using the RNA Polymerase Gene (rpoB). J. Clin. Microbiol.
41: 3387-3391
[Abstract]
[Full Text]